PrintClinical Trials Want Ads
Diabetes Specific
Type 1 Specific
Type 2 Specific
Neuropathy Trials
Pediatric Diabetes Specific
Not Diabetes Specific
WANTED:
The RETAIN Study is a clinical research study evaluating a protein called alpha-1 antitrypsin (AAT) in recently diagnosed type 1 diabetes patients.
AAT is a naturally occurring anti-inflammatory protein that affects immune cells that are thought to be involved in the development of type 1 diabetes. In mice, an injection of AAT can halt the destruction of beta cells, so doctors want to know if it will do the same in people, in a safe manner.
Get more information.
UPDATED: 1/4/2012
WANTED:
T1DAL (A Research Trial of Inducing Remission in New-onset Type 1 Diabetes with Alefacept)
This trial is testing whether repeated injections of an investigational study drug called alefacept (also called Amevive 
) will help people with newly-diagnosed type 1 diabetes continue to make some of their own insulin.
T1DAL (A Research Trial of Inducing Remission in New-onset Type 1 Diabetes with Alefacept) is a phase II clinical research trial in which the investigational study drug (alefacept) is tested for safety and whether it is effective in slowing or halting the progression of type 1 diabetes.
This trial plans to enroll 66 participants at fifteen clinical research centers across the U.S.
Get more information.
UPDATED: 1/4/2012
WANTED:
Driving Safely With Type 1 Diabetes
Research has shown that a few people with Type 1 diabetes are at an increased risk for having traffic accidents due to low blood sugars.
Researchers at the University of Virginia are conducting a study evaluating internet tools designed to:
Anonymously assess risk for all drivers with Type 1 diabetes of being in an accident and
Help reduce the chance of high-risk drivers being in a future collision.
The study is strictly confidential and the data collected will not be shared with any other person or agency. Participants may earn up to $270 in Internet gift cards.
Get More information. IRB-HSR# 15360
ADDED: 3/6/2012
WANTED:
Monitoring Autoimmunity in Diabetes
Description: The purpose of the "Monitoring Autoimmunity in Diabetes" study is to look at changes in the body that may occur with the development of type 1 diabetes. The samples taken as part of this study will be used to look at various genes, cells, and factors, which may be associated with type 1 diabetes and the immune system. These will be used to study why some people are at higher risk for developing diabetes and what happens to the immune system with the development of the disease. Participants may also qualify and be asked to participate in a separate clinical study that uses a novel magnetic resonance imaging (MRI) technique to noninvasively image insulitis (the destructive process in the pancreas that leads to loss of insulin production).
Recruiting: Seeking controls (no history of type 1 diabetes) and persons recently diagnosed with type 1 diabetes (within last 6 months). Must be 18 years or older.
For more information, contact: Sarah Szubowicz at (617) 309-4493 or sarah.szubowicz@joslin.harvard.edu
ADDED: 3/6/2012
WANTED:
The T1D Exchange Type 1 Diabetes Network (Pediatric, Adolescent and Young Adult Section)
Description: This Type 1 Diabetes (T1D) Exchange is a nationwide registry collecting information about children and adults with type 1 diabetes. The purpose of the registry is to gather information about people with type 1 diabetes to help better understand the natural course of type 1 diabetes and the effectiveness of current treatments. Participation in the registry involves completion of a questionnaire about medical and family history including diabetes diagnosis and treatment and laboratory test results. Annual updates of information are also part of the registry.
Recruiting: At the Joslin, individuals being followed in the Pediatric, Adolescent and Young Adult Section may be eligible to participate in this registry.
Contact: Camille Ratliff at 617-309-4477 or camille.ratliff@joslin.harvard.edu (CHS#2011-01)
ADDED: 3/6/2012
WANTED:
ELIXA Clinical Study on Type 2 Diabetes & Cardiovascular Disease
This is a research study of an investigational anti-diabetes medication to see if lowering blood sugar can prevent future cardiovascular events.
You may qualify to participate in the study if you:
- are over 30 years of age
- have had an Acute Coronary Syndrome event (heart attack/unstable angina) in the past 6 months
Qualified participants will receive:
- study related medical exams
- study-related investigational medication
- all diabetes testing supplies
- compensation for time and travel (where permitted)
For more information, call 1-800-788-0941 or visit http://www.hovclinicalresearch.com.
WANTED:
Type 2 Diabetes & Cardiovascular Disease (Cleveland, OH)
If you have type 2 diabetes mellitus and have a history of cardiovascular disease, you may qualify for a clinical research study. The purpose of this research study is to test the safety and effectiveness of the study medication in controlling glucose levels in patients with a current history of cardiovascular disease.
Qualified candidates must be:
- 18 years of age or older
- Currently taking medication to control glucose levels but have not yet achieved the level of glucose control doctors want for you with your type 2 diabetes
- Currently have a history of cardiovascular disease
Qualified participants will receive study medication and exams at no cost. Compensation will be provided for time and travel. Call Rapid Medical Research to see if you qualify at 888-460-2275 or visit http://www.rapidmedicalresearch.com/study-53-Type-2-Diabetes-&-Cardiovascular-Disease.
Find us on Facebook at http://www.facebook.com/RapidMedicalResearchInc.
ADDED: 11/26/2012
WANTED:
Type 2 Diabetes (Cleveland, OH)
If you have type 2 diabetes, are taking metformin and still not achieving adequate blood sugar levels, you may qualify for a clinical research study at Rapid Medical Research.
Volunteers must be at least 18 years of age.
Qualified participants will receive study medication or placebo and study-related exams at no cost. Compensation is provided for time and travel.
Get control of your type 2 diabetes.
Call Rapid Medical Research to see if you qualify at 888-460-2275 or visit http://www.rapidmedicalresearch.com/study-62-Type-2-Diabetes-(B).
Find us on Facebook at http://www.facebook.com/RapidMedicalResearchInc.
ADDED: 11/26/2012
WANTED:
Do you have difficulty in controlling your blood sugar levels on your current anti-diabetic medication? (Cleveland, OH)
If the answer is yes, you might be suitable to participate in a clinical research study looking at whether an investigational medication is safe and effective in people with type 2 diabetes who are taking metformin treatment but whose blood sugar levels are not effectively controlled.
You might be able to participate in the GRAND-302 Study if you:
- are 18 years of age or older
- have been diagnosed with type 2 diabetes
- have received less than 7 days of medication, or no medication other than metformin within the past 2 months
- have difficultly in controlling your blood sugar levels
The study will last for up to 42 weeks and will require between 13 and 15 visits to a study center. There is also the option to extend participation in the study to 122 weeks (just over 2 years). Suitable participants will receive study-related medication and health assessments at no cost.
To find out more, please contact Rapid Medical Research at 888-460-2275 or visit http://www.rapidmedicalresearch.com/study-66-Type-2-Diabetes-(T2).
Find us on Facebook at http://www.facebook.com/RapidMedicalResearchInc.
ADDED: 11/26/2012
WANTED:
Do you have type 2 diabetes? Have you had a heart attack or stroke in the past 2 years? Or, do you have high blood pressure, high cholesterol, or circulatory problems? (Cleveland, OH)
If the answer is yes, you may be suitable to participate in a clinical research study. This study will look at whether an investigational medication (a new medication that is under development) is safe and effective in people with type 2 diabetes.
You might be eligible to participate in the GRAND-306 Study if you:
- are 18 years of age or older
- have been diagnosed with type 2 diabetes
- have experienced heart problems or stroke, or have risk factors for heart disease, such as being a smoker, having high cholesterol, or high blood pressure
The study will last about 6 years and will involve approximately 23 visits to a study center and scheduled telephone calls. If you are suitable to participate in the GRAND-306 Study, you will receive study-related medication and health assessments at no cost.
To find out more, please contact Rapid Medical Research at 888-460-2275 or 216-682-0320, option 1, or visit http://www.rapidmedicalresearch.com/study-67-Type-2-Diabetes-(T6).
Find us on Facebook at http://www.facebook.com/RapidMedicalResearchInc.
ADDED: 11/26/2012
WANTED:
Type 2 Diabetes and Hepatitis B Vaccine (Cleveland, OH)
Rapid Medical Research is conducting a clinical research study for a hepatitis B vaccine in adults 20 years of age or older with or without type 2 diabetes.
This study will test how the body responds to a hepatitis B vaccine for adults with or without type 2 diabetes.
You may join this study if:
- you are 20 years of age or older
- have been diagnosed with diabetes within the past 5 years or never had diabetes
- you have never had a hepatitis B vaccine
- you have never had a hepatitis B infection
Qualified participants will receive study vaccines and study-related exams at no cost. Compensation will be provided for time and travel.
Call Rapid Medical Research to see if you qualify at 888-460-2275 or visit http://www.rapidmedicalresearch.com/study-58-Hepatitis-B-Vaccine-.
Find us on Facebook at http://www.facebook.com/RapidMedicalResearchInc.
ADDED: 11/26/2012
WANTED:
Advanced Clinical Research (ACR) in Boise, ID is conducting a clinical research study for hepatitis B vaccine in adults 20 years of age or older with or without type 2 diabetes.
This study will test how the body responds to a hepatitis B vaccine for adults with or without type 2 diabetes.
You may join this study if:
- You are 20 years of age or older
- You have been diagnosed with diabetes within the past 5 years or never had diabetes
- You have never had a hepatitis B vaccine
- You have never had a hepatitis B infection
Qualified participants will receive study vaccines and study-related exams at no cost. Compensation will be provided for time and travel.
Call ACR to see if you qualify at 208-377-8653 x102 or x104 or visit http://www.acr-research.com/study-128-Hepatitis-B-Vaccine-Boise.
Find us on Facebook at www.facebook.com/ACRIdaho
ADDED: 11/13/2012
WANTED:
Did you know that stress can affect your diabetes?
Taking steps to manage your stress can lead to you feeling better mentally and physically. Researchers at the University of South Florida are offering adults with type 2 diabetes a free online program that will teach you ways that may help to manage your stress and improve your mood. For more information visit www.diabetesstressrelief.com. You can also contact the researcher directly at 1.800.576.3901 or diabetesstressrelief@gmail.com.
UPDATED: 1/4/2012
WANTED:
Do you have type 2 diabetes? Are regular diet and exercise not working, or are you take Metformin and it's not enough?
If so, you may be eligible to be in a clinical research study evaluating the safety and effectiveness of an investigational medication for the treatment of type 2 diabetes.
Eligible volunteers will receive all study related:
- Physical exams
- Lab tests
- Investigational medication(s) or placebo
- Diet and exercise counseling
- Glucometer and blood sugar testing supplies
- Reimbursement for time and travel expenses
For more information, please call Diablo Clinical Research at 925-930-7267.
UPDATED: 1/4/2012
WANTED:
Do you have type 2 Diabetes? We are enrolling adult volunteers now.
Help us explore pathways to diabetes management.
If you have type 2 diabetes, find out if you qualify for a clinical research study of an investigational oral diabetes medication.
You may be eligible if:
- You have a confirmed diagnosis of type 2 diabetes, and
- You are age 30 or older and have had a heart attack or stroke, or other heart or vascular problem OR
- You are age 50 or older and you have been told by your doctor that you are at high risk for heart disease
If eligible to participate, you will be seen by a study doctor and receive study-related testing and study medication at no cost.
Once enrolled, you may be reimbursed for parking and travel expenses.
For more information, please contact Diablo Clinical Research at 925-930-7267.
UPDATED: 1/4/2012
WANTED:
If you have type 2 diabetes, you may be interested in learning more about a clinical research study that may help with type 2 Diabetes.
You may qualify to participate in this study if you are between the ages 18 and 70 and have trouble controlling your blood sugar levels with your current regimen.
Study participants will receive at no cost:
- Study-related medications
- Diet and exercise counseling
- Study-related medical care
Compensation for your time and travel may also be available.
For more information, please call Diablo Clinical Research at 925-930-7267.
UPDATED: 1/4/2012
WANTED:
Do you have type 2 diabetes? Consider volunteering?
A clinical research study is evaluating how an investigational medication may give you better control of your type 2 diabetes. To qualify, you must be between 18 and 80 years of age and taking metformin alone, or in combination with another oral diabetes drug for three months or longer. Qualified participants will receive all study-related care and study medications at no cost, and may be compensated for time and travel.
For more information please call Diablo Clinical Research at 925-930-7267.
UPDATED: 1/4/2012
WANTED:
The HARMONY Study
When your type 2 diabetes is out of control, finding Harmony is essential.
If you're having trouble controlling your diabetes, consider participating in HARMONY, a research study evaluating an investigational diabetes medication that's taken only once a week.
Even when you eat healthy, exercise, and take your prescribed medications, managing your blood sugar can still be a challenge. You're not alone. Many people living with type 2 have difficulty controlling their disease, even when they follow their current treatment plans.
Now, the HARMONY program is evaluating a new, investigational diabetes medication for its ability to better control Type 2 Diabetes. This investigational medication may not need to be taken as frequently as many current diabetes drugs, potentially making treatment more convenient for diabetes patients.
If you're having difficulty controlling your diabetes even with your current efforts, consider the HARMONY program.
UPDATED: 1/4/2012
WANTED:
Do you want to change the future?
If you have type 2 diabetes, you can do something: Help others like you!
Diabetes is one of the most serious health problems of our time. People with type 2 diabetes have 2-4 times increased risk of heart disease.
To further understand the increased risk of heart disease and explore ways to reduce it, Diablo Clinical Research, Walnut Creek, CA, is seeking people with type 2 diabetes to take part in a new clinical study involving a novel treatment that has been demonstrated to improve glycemic control in people with type 2 diabetes.
To join the trial you must be:
- Over the age of 50
- Have type 2 diabetes and cardiovascular disease
- Able to attend seven visits during the first year of the trial and two annual visit until the end of 2015
Patients included in the trial will receive study related care via regular health-checks and medical testing, access to trial medications and blood glucose testing equipment as well as compensation for your time and travel.
For more information, please contact Diablo Clinical Research at 925-930-7267.
UPDATED: 1/4/2012
WANTED:
The Effects of Type 2 Diabetes on Brain Function Study
Description: In this study, we are looking at whether people with Type 2 diabetes show early signs of changes in their thinking processes. We are looking for people both with and without type 2 diabetes so we can compare their thinking processes. The study involves 2 visits, one 2-4 hour visit to the Joslin Diabetes Center and one 1 hour visit to Beth Israel Medical Center in Boston. Study procedures involve thinking tests, completing questionnaires, blood tests and a MRI Scan to examine performance on thinking tests. People without a prior diagnosis of diabetes will also be given a sugary drink at their visit to see how their body processes sugar.
Recruiting: Seeking participants between the ages of 45-65 with a diagnosis of Type 2 Diabetes who are not on metformin, or TZD's (pioglitazone, rosiglitazone). We are also seeking participants between the ages of 45-65 who have not been diagnosed with Diabetes. Moderate proficiency in English is Required. Monetary compensation is available and the study will validate parking on days of study visits.
Contact: If you are interested in learning more about this study, please call Veronica Flores at 617-309-4326 or by email at veronica.flores@joslin.harvard.edu (CHS#2010-04)
ADDED: 3/6/2012
WANTED:
Study of Heart Disease in people with Type 2 Diabetes
Description: The study aims to identify the genes that cause some people with diabetes to be at a higher risk for developing heart disease. This is a one visit study. For all subjects the study involves completing questionnaires, brief physical exam, and blood samples. Subjects without history of heart disease will also have an exercise tolerance test unless they have had one within the past 12 months. Compensation and free parking are available, and all information will be held strictly confidential.
Recruiting: Joslin or BIDMC patients with type 2 diabetes and heart disease between 30 and 75 years old. Joslin patients with type 2 diabetes and no heart disease between 55 and 75 years old.
Contact: Elizabeth Goheen at 617-309-4165 or email elizabeth.goheen@joslin.harvard.edu (CHS#99-20)
ADDED: 3/6/2012
WANTED:
SLIMM T2D Study: Surgery of Lifestyle with Intensive Medical Management in the treatment of Type 2 Diabetes
Description: We are comparing whether bariatric surgery (weight loss surgery) or a diabetes and intensive medical and weight management program is more effective for the treatment of type 2 diabetes in patients who are modestly overweight. Participants will be randomized (like the flip of a coin) to surgical or non-surgical treatment. Participants randomized to surgery will have their surgery performed at the Brigham and Women's Hospital, Boston. Follow up visits for surgical groups can vary based on the type of surgery performed. Those participants randomized to the Intensive Medical Management program will have several visits at the Joslin Diabetes Center, Boston which include the following: Weekly evening meetings over 13 weeks for group education and support led by a physician, diabetes nurse educator, nutritionist, exercise physiologist and behavior counselor Monthly follow up visits after 13 weeks Both surgical and non-surgical groups are followed over three years.
Recruiting: We are seeking clinical Research Volunteers with type 2 diabetes and excess weight, between 21-65 years of age, who are willing to have bariatric (weight loss) surgery or participate in an intensive medical (non-surgical) diabetes and weight management program.
Contact: Kerri Clancy at 617-525-7388 or email SLIMMT2D@Partners.Org
ADDED: 3/6/2012
WANTED:
Are you having gastric bypass surgery? Do you have type 2 diabetes?
We are looking for clinical research volunteers who are going to have a gastric bypass surgery for weight loss at Brigham and Women's Hospital and who have type 2 diabetes. We are conducting a study on how gastric bypass weight loss surgery helps to improve blood sugars in those with type 2 diabetes. The study involves 3 visits before your surgery, and 2 visits afterwards. The first visit will be at either Brigham and Women's Hospital or Joslin Diabetes Center, and all the visits after that will be at Joslin Diabetes Center. During these visits we will study how your body responds to sugar and the hormone insulin. We are looking for people 21 to 60 years of age. You will be compensated for your time. Please contact us if you would be willing to participate in this important research study.
Contact: Jennifer Panosian at 617-264-2731 or email jennifer.panosian@joslin.harvard.edu (CHS#2010-03)
ADDED: 3/6/2012
WANTED:
Factors Affecting Type 2 Diabetes Treatment Adherence
Description: This is research study investigating whether certain factors, such as the relationship with your physician, affect how you follow through with type 2 diabetes treatment recommendations (e.g., following a diet, exercising, monitoring blood sugar, etc.).
Eligible participants are asked to complete an anonymous online survey. The survey should take no longer than 20 minutes to complete, and $2 will be donated to the American Diabetes Association for each survey submitted.
To access the survey, please clickhere
Recruiting: To participate, you must be: a) at least 18 years old; b)able to read and write in English; c) have received a diagnosisof type 2 disbetes at least two (2) years ago; d) able to carry out diabetes self-care activities on your own; and e) have met with the same physician who treats you for type 2 diabetes on at least three (3) separate occasions over the past two (2) years.
Contact: Please contact Jessie Fontanella, MSEd at (978) 807-3171 or fontanella@fordham.edu
ADDED: 3/6/2012
WANTED:
Is diabetes causing you pain in both legs or both feet? For at least the past 6 months?
If so, please contact our medical research study of an investigational medication for the pain in both legs or both feet caused by diabetes.
Qualified participants:
- Are 18 to 70 years old
- Have pain in both legs or both feet caused by diabetes
- Have experienced this pain for at least the past 6 months
Qualified participants will receive all study-related care, evaluations, and medications at no charge.
Participation is at no charge and compensation is available for time and travel.
To learn more, please call Diablo Clinical Research at 925-930-7267.
UPDATED: 1/4/2012
WANTED:
Are you a diabetic and have pain in your feet?
Diablo Clinical Research is currently conducting a clinical trial to test an investigational medication for people that have diabetes and suffer from Neuropathy (pain in feet). Qualified participants must be 18 to 75 years of age, in good general health and able to attend 9 scheduled visits.
Qualified Participants May Receive:
- Investigational medication administered by intravenous infusion
- Compensation for time and travel
For more information please call Diablo Clinical Research at 925-930-7267.
UPDATED: 1/4/2012
WANTED:
The T1D Exchange Type 1 Diabetes Network
Description: The Type 1 Diabetes (T1D) Exchange ia a nationwide registry collecting information about children and adults with type 1 diabetes. The purpose of the registry is to gather information about people with type 1 diabetes to help better understand the natural course of type 1 diabetes and the effectiveness of current treatments. Participation in the registry involves completion of a questionnaire about medical and family history including diabetes diagnosis and treatment and laboratory test results Annual updates of information are also part of the registry.
Recruiting: At the Joslin, individuals being followed in the Pediatric, Adolescent and Young Adult Section may be eligible to participate in this registry.
Contact: Camille Ratliff at (617) 309-4477 or Camille.Ratliff@Joslin.Harvard.edu (CHS#2011-01)
ADDED: 3/6/2012
WANTED:
The Tolerance Study
Description: This study is trying to help us better understand what causes type 1 diabetes to help find new ways to prevent or reverse the disease. The study is being done with researchers at Harvard Medical School and is funded by the Juvenile Diabetes Research Foundation. The study visit includes the completion of questionnaires and a blood draw.
Recruiting: Individuals, ages 18 years and older, both with and without type 1 diabetes.
Contact: Roxanne Phillips at 617-309-2481 or roxanne.phillips@joslin.harvard.edu (CHS#02-15)
ADDED: 3/6/2012
WANTED:
CGM improve study
Description: The purpose of this study is to find out how to make it easier for children and teens with type 1 diabetes to use continuous glucose monitors (CGM) over a long period of time. The study involves 12 visits over a 24-month period with additional phone contacts between visits. The extra three visits occur during the first six months of the study: the rest of the visits will occur at routine clinic visits. Families randomized to the intervention group will receive a family based behavioral intervention providing support and education regarding use of the CGM. Families in the usual care group will receive this information at the end of the study. Youth in both groups will wear a CGM device throughout the study. Families will be asked to complete surveys at various intervals over the course of the study and lab work will be collected for the youth in the study.
Recruiting: Children and teens, ages 8-17 years, who have had type 1 diabetes for at least 1 year and who are receiving care at Joslin and their parents or legal guardians.
Contact: Kaitlin Gaffney at 617-309-4475 or kaitlin.gaffney@joslin.harvard.edu (CHS#2010-28)
ADDED: 3/6/2012
WANTED:
Type 1 Diabetes Risk Assessment- The Natural History Study - TrialNet
Description: This study aims to identify youth and adults at risk for type 1 diabetes by testing for diabetes-related antibodies in relatives of people with type 1 diabetes. It involves a single blood test. People who test positive will be eligible for further testing and may be eligible to participate in prevention trials.
Recruiting: Parents, children, & siblings, ages 1-45, and cousins, grandchildren, nieces, & nephews, ages 1-20, of people with type 1 diabetes.
Contact: Hui Zhang at 617-309-2524 or hui.zhang@joslin.harvard.edu (CHS#03-33)
ADDED: 3/6/2012
WANTED:
SUGAR MGH Study: Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Description: The SUGAR MGH Research Study will evaluate whether the different genes people inherit change the response to medications that are commonly used to treat type 2 diabetes, metformin and glipizide. As part of the study participants will be asked to take these medications and will also be given a sugar drink.
The study involves two visits to the Joslin Diabetes Clinic one week apart, the first visit takes about 5 hours and the second about 3 hours. Blood will be drawn at both visits. Participants will receive monetary compensation, a parking voucher and a free meal for each completed visit.
Recruiting: We are seeking research volunteers over the age of 18 years who have diabetes but are not currently on diabetes medication, and/or who may be at risk for diabetes (for example, risk factors include high or "borderline-high" blood sugars, being overweight, having a history of gestational diabetes (diabetes during pregnancy), being an ethnic minority, or having a first degree relative with type 2 diabetes).
Contact: Corinne Barbato at corinne.barbato@joslin.harvard.edu or 617-309-4478
ADDED: 3/6/2012
WANTED:
Gastric Bypass Study
Are you feeling well after your gastric bypass surgery 2-5 years ago and between the ages of 30 and 60? Researchers at the Joslin Diabetes Center are seeking volunteers to participate in a research study to investigate people who have successfully lost weight after gastric bypass surgery.
Study involves two, 6-hour visits to the Boston Joslin Diabetes Center. Free Parking. Monetary compensation.
Contact: Jennifer Panosian at 617-264-2731 or email at jennifer.panosian@joslin.harvard.edu (CHS # 91-04)
ADDED: 3/6/2012
You are subscribed!
You are subscribed!
You are subscribed!
Readers ask me all the time [lie] about the diabetes supplies we use for Charlie. I can’t tell you how many times [0] I’ve been stopped on the street [more lies] by a loyal blog reader wanting to know what blood glucose meter we use or what brand of finger pricker we employ. To calm the masses [not], I’ve decided the time is right to share our secret sauce; to reveal the tools of our trade. Today we take a look at … The Finger Pricker ...
